Association between ligand-induced conformational changes of integrin α(IIb)β3 and α(IIb)β3-mediated intracellular Ca2+ signaling

Blood

Volumn 92, Issue 10, 1998, Pages 3675-3683

  Honda, Shigenori ^b   Tomiyama, Yoshiaki ^a   Aoki, Toshiaki ^b   Shiraga, Masamichi ^b   Kurata, Yoshiyuki ^b   Seki, Jiro ^b   Matsuzawa, Yuji ^b  

^a OSAKA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 [[4 [[4 (AMINOIMINOMETHYL)PHENYL]AMINO] 1,4 DIOXOBUTYL]AMINO] 4 PENTYNOIC ACID; 4 (4 AMIDINOPHENOXY)BUTYRYLASPARTYLVALINE; CALCIUM ION; DALTROBAN; FIBRINOGEN; FR 169824; FR 184764; INTEGRIN; LAMIFIBAN; LIGAND; MONOCLONAL ANTIBODY; THROMBIN; THROMBOXANE A2; TIROFIBAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0032533571     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3675.422k38_3675_3683     Document Type: Article

References (46)

1. Hynes RO: In te grins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
2. Clark EA, Brugge JS: Integrin and signal transduction pathways: The road taken. Science 268:233, 1995
3. Schwartz MA, Schaller MD, Ginsberg MH: Integrins; emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 11:549, 1995
4. Yamada KM, Miyamoto S: Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 7:681, 1995
5. Ruggeri ZM: New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol 31:229, 1994
6. Ginsberg MH, Frelinger AL III, Lam S-T, Forsyth J, MacMillan R, Plow EF, Shattil SJ: Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-III a with conformation-specific monoclonal antibodies. Blood 76:2017, 1990
7. Ingber DE, Prusty D, Frangioni JV, Edward J, Cragoe J, Lechene C, Schwartz MA: Control of intracellular pH and growth by fibronectin in capillary endothelial cells. J Cell Biol 110:1803, 1990
8. Schwartz MA: Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol 120:1003, 1993
9. Frelinger AL III, Lam SC-T, Plow EF, Simth MA, Loftus JC, Ginsberg MH: Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem 263:12397, 1988
10. Frelinger AL III, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC-T, Ginsberg MH: Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformera αIIbβ3. J Biol Chem 265:6346, 1990
11. Kouns WC, Wall CD, White MM, Fox CF, Jennings LK: A conformation-dependent epitope of human platelet glycoprotein IIIa. J Biol Chem 265:20594, 1990
12. Tomiyama Y, Tsubakio T, Piotrowicz RS, Kurata Y, Loftus JC, Kunicki TJ: The Arg-Gly-Asp (ROD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules. Blood 79:2303, 1992
13. Bajt ML, Loftus JC: Mutation of a ligand binding domain of β3 integrin. J Biol Chem 269:20913, 1994
14. 3 subunit. J Biol Chem 270:11947, 1995
15. Loftus JC, Plow EF, Frelinger AL III, D' Souza SE, Dixon D, Lacy J, Sorge J, Ginsberg MH: Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci USA 84:7114, 1987
16. Du X, Gu M, Weisel JW, Nagaswami C, Bennett JS, Bowditch R, Ginsberg MH: Long range propagation of conformational changes in integrin αIIbβ3. J Biol Chem 268:23087, 1993
17. Aoki T, Cox D, Senzaki K, Seki J, Tanaka A, Takasugi H, Motoyama Y: The anti-platelet and anti-thrombotic effects of FK633, a peptide-minetic GPIIb/IIIa antagonist. Thromb Res 81:439, 1996
18. Peerlinck K, Lepeleire ID, Goldberg M, Farrell D, Barrett J, Hand E, Panebianco D, Deckmyn H, Verrmylen J, Arnout J: MK-383 (L-700, 462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man. Circulation 88:1512, 1993
19. Carteaux J-P, Steiner B, Roux Sb: Ro 44-9883, a new non-peptidic GPIIb-IIIa antagonist prevents platelet loss in a guinea pig model of extracorporeal circulation. Thromb Haemost 70:817, 1993
20. Frederick LG, Suleymanov OD, King LW, Salyers AK, Nicholson NS, Feigen LP: The protective dose of the potent GPIIb/IIIa antagonist SC-54701A is reduced when used in combination with aspirin and heparin in a canine model of coronary artery thrombosis. Circulation 93:129, 1996
21. Raddatz P, Gante J: Recent developments in glycoprotein IIb/IIIa antagonists. Exp Opin Ther Patents 5:1163, 1995
22. Klimm JL, Kloczewiak M, Lindon JN: Comparison of the inhibitory activity of free and albumin bound thromboxane receptor antagonist BM13.505 on U46619 induced platelet aggregation. Thromb Haemost 62:191, 1989 (abstr)
23. Faraday N, Goldschmidt-Clermont P, Dise K, Bray PF: Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med 123:728, 1994
24. 2+ exchanger. Blood 88:2594, 1996
25. 2+ influx mediated through the GPIIb/IIIa complex during platelet activation. FEBS Lett 225:228, 1987
26. Yamaguchi A, Tanoue K, Yamazaki H: Secondary signals mediated by GPIIb/IIIa in thrombin-activated platelets. Biochim Biophys Acta 1054:8, 1990
27. Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kanayama Y, Kurata Y, Matsuzawa Y: Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann thrombasthenia. Thromb Haemost 73:756, 1995
28. Kouns WC, Weller T, Hadvary P, Jennings LK, Steiner B: Identification of a peptidomimetic inhibitor with minimal effects on the conformation of GPIIb-IIIa. Blood 80:165a, 1992 (abstr, suppl 1)
29. Steiner B, Hating P, Jennings L, Kouns WC: Five independent neo-epitopes on GPIIb-IIIa are differentially exposed by two potent peptidomimetic platelet inhibitors. Thromb Haemost 69:782, 1993 (abstr)
30. Diaz-González F, Forsyth J, Steiner B, Ginsberg MH: Transdominant inhibition of integrin function. Mol Biol Cell 7:1939, 1996
31. Phillips DR, Charo IF, Scarborough RM: GPIIb-IIIa: The responsive integrin. Cell 65:359, 1991
32. Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267:883, 1995
33. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM: Integrin function: Molecular hierarchies of cytoskeletal and signalling molecules. J Cell Biol 131:791, 1995
34. Tokuhira M, Handa M, Kamata T, Oda A, Katayama M, Tomiyama Y, Murata M, Kawai Y, Watanabe K, Ikeda Y: A novel regulatory epitope defined by a muhne monoclonal antibody to the platelet GPIIb-IIIa complex (αIIbβ3 integrin). Thromb Haemost 76: 1038, 1996
35. 2 synthesis. Thromb Haemost 79:1184, 1998
36. Blockmans D, Deckmyn H, Vermylen J: Platelet activation. Blood Rev 9:143, 1995
37. Murphy N, Jennings L, Pratico D, Doyle C, Fitzgerald DJ: Functional relevance of LIBS expression in the response to platelet glycoprotein antagonists in vivo. Thromb Haemost 73:1314, 1995 (abstr)
38. 3 and integrin-associated protein. J Cell Biol 130:745, 1995
39. 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129:867, 1995
40. Chen Y, O'Toole TE, Shipley T, Forsyth J, LaFlamme SE, Yamada KM, Shattil SJ, Ginsberg MH: "Inside-out" signal transduction inhibited by isolated integrin cytoplasmic domains. J Biol Chem 269:18307, 1994
41. Ylanne J, Chen Y, O'Toole TE, Loftus JC, Takada Y, Ginsberg MH: Distinct function of integrin α and β subunit cytoplasmic domains in cell spreading and formation of focal adhesion. J Cell Biol 122:223, 1993
42. 3 (glycoprotein IIb-IIIa) in a variant of Grantzmann thrombasthenia. Proc Natl Acad Sci USA 89:10169, 1992
43. 3 (platelet glycoprotein IIb-IIIa). Blood 84:1857, 1994
44. Coller BS: Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics. J Clin Invest 99:1467, 1997
45. Cines DB: Glycoprotein IIb/IIIa antagonists: Potential induction and detection of drug-dependent antiplatelet antibodies. Am Heart J 135:5152, 1998
46. Hamberg M, Svensson J, Samuelsson B: Thromboxanes: Anew group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994, 1975